ICD10 code of Ollier disease and ICD9 code

Ollier disease is classified under the ICD-10 code Q78.4 (Enchondromatosis) and the ICD-9 code 756.4 (Chondrodystrophy). These codes are used by healthcare providers to document this rare condition, which is characterized by the presence of multiple benign cartilaginous tumors, known as enchondromas, typically affecting the long bones.

What is the clinical significance of Ollier disease?

Ollier disease is a rare, non-hereditary disorder defined by the development of multiple enchondromas. These benign tumors primarily arise within the medullary cavity of bones, often leading to skeletal deformities, limb length discrepancies, and pathological fractures. Because Ollier disease manifests differently in every patient, clinical management often requires a multidisciplinary approach involving orthopedists, radiologists, and geneticists. Within the DiseaseMaps community, 279 people with Ollier disease have connected to share their unique journeys, highlighting the importance of personalized care plans for those managing the physical and emotional impact of this condition.

How are the ICD codes used for Ollier disease?

In medical billing and clinical documentation, the ICD-10 code Q78.4 for Ollier disease is essential for ensuring patients receive appropriate insurance coverage for diagnostic imaging and orthopedic interventions. While ICD-9 code 756.4 is largely historical, it remains relevant in older medical records and longitudinal research studies. Accurate coding is critical for patients with Ollier disease, as it facilitates the tracking of specialized care and long-term monitoring for potential malignant transformation of enchondromas into chondrosarcoma.

What are the key clinical features and risks?

The progression of Ollier disease is highly variable, often becoming apparent in early childhood. Clinicians focus on monitoring for complications that may arise as the skeleton matures. Key clinical considerations include:

• Limb Length Discrepancy: Asymmetric growth due to the presence of enchondromas near the growth plates.


• Pathological Fractures: Increased fragility in bones affected by the thinning of the cortex.


• Malignant Transformation: A small but significant lifetime risk—estimated by some literature to be between 25% and 30%—of enchondromas evolving into secondary chondrosarcoma.


• Skeletal Deformities: Visible or functional irregularities in the hands, feet, or long bones.

Is there a genetic component to Ollier disease?

Unlike many other skeletal dysplasias, Ollier disease is typically sporadic, meaning it is not inherited from a parent. Research suggests it is caused by post-zygotic somatic mutations, most notably in the IDH1 or IDH2 genes. Because these mutations occur after conception, the condition is not passed down through families. Understanding the sporadic nature of Ollier disease is often a relief for parents who may be concerned about the recurrence risk in future children.

Next steps

• Consult with an orthopedic oncologist or a specialist in skeletal dysplasias to establish a baseline imaging schedule.


• Join the DiseaseMaps community to connect with 279 other individuals who understand the daily challenges of Ollier disease.


• Maintain a comprehensive medical file, including all imaging reports, to ensure continuity of care across different specialists.


• Monitor for new or worsening pain, which should always be promptly evaluated by your medical team to rule out malignant transformation.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: ORPHA647 (Enchondromatosis)


• NIH GARD: Genetic and Rare Diseases Information Center - Ollier disease


• OMIM: Entry #166000 (Enchondromatosis)


• PubMed: Clinical reviews on the malignant potential of multiple enchondromatosis